ARTICLE | Clinical News
Favipiravir: Completed Phase III enrollment
March 23, 2015 7:00 AM UTC
MediVector completed enrollment of 2,021 adults with uncomplicated influenza in the 2 double-blind, placebo-controlled, international Phase III FAVOR trials evaluating oral favipiravir for 5 days. Pat...